RxDoctor Payments Data

Cristina Keusch

Boca Raton, FLNPI 1326192451

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $45,717 of the $54,757 with a category attached, or 83.5%. AbbVie accounts for 96.8% of it on its own, with 11 other manufacturers making up the rest.

$54,757in general payments, 2019–2025

Across 310 payments — averaging $176.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$53K
  • Mentor Worldwide LLC$527
  • Musculoskeletal Transplant Foundation Inc.$423
  • Davol Inc.$147
  • Merz North America, Inc.$131
  • Johnson & Johnson$125
  • plus $399 from 6 others

What the payments were for

  • Speaking & faculty fees$45,71783%
  • Food & beverage$6,34012%
  • Gifts$2,7005%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib27$597
Mupirocin21$121
Ondansetron OdtOndansetron24$71
Cephalexin28$63
Zolpidem Tartrate16$38

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →